Literature DB >> 20154089

Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent.

Michel Dron1, Mohammed Moudjou, Jérôme Chapuis, Muhammad Khalid Farooq Salamat, Julie Bernard, Sabrina Cronier, Christelle Langevin, Hubert Laude.   

Abstract

The abnormally folded form of the prion protein (PrP(Sc)) accumulating in nervous and lymphoid tissues of prion-infected individuals can be naturally cleaved to generate a N-terminal-truncated fragment called C2. Information about the identity of the cellular proteases involved in this process and its possible role in prion biology has remained limited and controversial. We investigated PrP(Sc) N-terminal trimming in different cell lines and primary cultured nerve cells, and in the brain and spleen tissue from transgenic mice infected by ovine and mouse prions. We found the following: (i) the full-length to C2 ratio varies considerably depending on the infected cell or tissue. Thus, in primary neurons and brain tissue, PrP(Sc) accumulated predominantly as untrimmed species, whereas efficient trimming occurred in Rov and MovS cells, and in spleen tissue. (ii) Although C2 is generally considered to be the counterpart of the PrP(Sc) proteinase K-resistant core, the N termini of the fragments cleaved in vivo and in vitro can actually differ, as evidenced by a different reactivity toward the Pc248 anti-octarepeat antibody. (iii) In lysosome-impaired cells, the ratio of full-length versus C2 species dramatically increased, yet efficient prion propagation could occur. Moreover, cathepsin but not calpain inhibitors markedly inhibited C2 formation, and in vitro cleavage by cathepsins B and L produced PrP(Sc) fragments lacking the Pc248 epitope, strongly arguing for the primary involvement of acidic hydrolases of the endolysosomal compartment. These findings have implications on the molecular analysis of PrP(Sc) and cell pathogenesis of prion infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154089      PMCID: PMC2856230          DOI: 10.1074/jbc.M109.083857

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Screening slaughtered cattle for BSE.

Authors:  J P Deslys; E Comoy; S Hawkins; S Simon; H Schimmel; G Wells; J Grassi; J Moynagh
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

3.  Scrapie strains maintain biological phenotypes on propagation in a cell line in culture.

Authors:  C R Birkett; R M Hennion; D A Bembridge; M C Clarke; A Chree; M E Bruce; C J Bostock
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

4.  Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.

Authors:  Michel Dron; Françoise Dandoy-Dron; Muhammad Khalid Farooq Salamat; Hubert Laude
Journal:  J Gen Virol       Date:  2009-04-01       Impact factor: 3.891

5.  Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein.

Authors:  D Vilette; O Andreoletti; F Archer; M F Madelaine; J L Vilotte; S Lehmann; H Laude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

6.  Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp.

Authors:  J L Vilotte; S Soulier; R Essalmani; M G Stinnakre; D Vaiman; L Lepourry; J C Da Silva; N Besnard; M Dawson; A Buschmann; M Groschup; S Petit; M F Madelaine; S Rakatobe; A Le Dur; D Vilette; H Laude
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice.

Authors:  E Flechsig; D Shmerling; I Hegyi; A J Raeber; M Fischer; A Cozzio; C von Mering; A Aguzzi; C Weissmann
Journal:  Neuron       Date:  2000-08       Impact factor: 17.173

8.  Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins.

Authors:  Yuzuru Taguchi; Zhen-Dan Shi; Brian Ruddy; David W Dorward; Lois Greene; Gerald S Baron
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

9.  Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions.

Authors:  Silvia Jordans; Sasa Jenko-Kokalj; Nicole M Kühl; Sofia Tedelind; Wolfgang Sendt; Dieter Brömme; Dusan Turk; Klaudia Brix
Journal:  BMC Biochem       Date:  2009-09-22       Impact factor: 4.059

10.  Strain-associated variations in abnormal PrP trafficking of sheep scrapie.

Authors:  Martin Jeffrey; Gillian McGovern; Caroline M Goodsir; Silvia Síso; Lorenzo González
Journal:  Brain Pathol       Date:  2008-04-08       Impact factor: 6.508

View more
  38 in total

1.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

2.  Effects of FlAsH/tetracysteine (TC) Tag on PrP proteolysis and PrPres formation by TC-scanning.

Authors:  Yuzuru Taguchi; Lindsay A Hohsfield; Jason R Hollister; Gerald S Baron
Journal:  Chembiochem       Date:  2013-08-13       Impact factor: 3.164

3.  Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway.

Authors:  Didier Vilette; Karine Laulagnier; Alvina Huor; Sandrine Alais; Sabrina Simoes; Romao Maryse; Monique Provansal; Sylvain Lehmann; Olivier Andreoletti; Laurent Schaeffer; Graça Raposo; Pascal Leblanc
Journal:  Cell Mol Life Sci       Date:  2015-06-06       Impact factor: 9.261

4.  MEK1 transduces the prion protein N2 fragment antioxidant effects.

Authors:  C L Haigh; A R McGlade; S J Collins
Journal:  Cell Mol Life Sci       Date:  2014-11-13       Impact factor: 9.261

5.  Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.

Authors:  Jingjing Liang; Wei Wang; Debra Sorensen; Sarah Medina; Sergei Ilchenko; Janna Kiselar; Witold K Surewicz; Stephanie A Booth; Qingzhong Kong
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

6.  Strain-specific role of RNAs in prion replication.

Authors:  Paula Saá; Gian Franco Sferrazza; Gregory Ottenberg; Anja M Oelschlegel; Kerri Dorsey; Corinne I Lasmézas
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

7.  Comparison of abnormal isoform of prion protein in prion-infected cell lines and primary-cultured neurons by PrPSc-specific immunostaining.

Authors:  Misaki Tanaka; Ai Fujiwara; Akio Suzuki; Takeshi Yamasaki; Rie Hasebe; Kentaro Masujin; Motohiro Horiuchi
Journal:  J Gen Virol       Date:  2016-06-06       Impact factor: 3.891

8.  A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.

Authors:  Carola Munoz-Montesino; Djabir Larkem; Clément Barbereau; Angélique Igel-Egalon; Sandrine Truchet; Eric Jacquet; Naïma Nhiri; Mohammed Moudjou; Christina Sizun; Human Rezaei; Vincent Béringue; Michel Dron
Journal:  J Biol Chem       Date:  2020-08-11       Impact factor: 5.157

Review 9.  Mammalian prions: tolerance to sequence changes-how far?

Authors:  Muhammad Khalid Salamat; Carola Munoz-Montesino; Mohammed Moudjou; Human Rezaei; Hubert Laude; Vincent Béringue; Michel Dron
Journal:  Prion       Date:  2012-12-11       Impact factor: 3.931

10.  Prion disease tempo determined by host-dependent substrate reduction.

Authors:  Charles E Mays; Chae Kim; Tracy Haldiman; Jacques van der Merwe; Agnes Lau; Jing Yang; Jennifer Grams; Michele A Di Bari; Romolo Nonno; Glenn C Telling; Qingzhong Kong; Jan Langeveld; Debbie McKenzie; David Westaway; Jiri G Safar
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.